Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

1920 ARTÍCULOS , VIENDO DEL 136 AL 150

Dual-target inhibitors of cholinesterase and GSK-3β to modulate Alzheimer's disease

He J, Tam KY.

Drug Discov Today. 2024 Apr;29(4):103914. doi: 10.1016/j.drudis.2024.103914. Epub 2024 Feb 8.

The neurotransmitter puzzle of Alzheimer's: Dissecting mechanisms and exploring therapeutic horizons

Sharma M, Pal P, Gupta SK.

Brain Res. 2024 Apr 15;1829:148797. doi: 10.1016/j.brainres.2024.148797. Epub 2024 Feb 10.

Developing a PRogram to Educate and Sensitize Caregivers to Reduce the Inappropriate Prescription Burden in the Elderly with Alzheimer's Disease (D-PRESCRIBE-AD): Trial protocol and rationale of an open-label pragmatic, prospective randomized controlled trial

Singh S, Cocoros NM, Li X, Mazor KM, Antonelli MT, Parlett L, Paullin M, Harkins TP, Zhou Y, Rochon PA, Platt R, Dashevsky I, Massino C, Saphirak C, Crawford SL, Gurwitz JH.

PLoS One. 2024 Feb 12;19(2):e0297562. doi: 10.1371/journal.pone.0297562. eCollection 2024.

The role of microglia heterogeneity in synaptic plasticity and brain disorders: Will sequencing shed light on the discovery of new therapeutic targets?

You Y, Chen Z, Hu WW.

Pharmacol Ther. 2024 Mar;255:108606. doi: 10.1016/j.pharmthera.2024.108606. Epub 2024 Feb 10.

The contribution of β-amyloid, Tau and α-synuclein to blood-brain barrier damage in neurodegenerative disorders

Wu YC, Bogale TA, Koistinaho J, Pizzi M, Rolova T, Bellucci A.

Acta Neuropathol. 2024 Feb 12;147(1):39. doi: 10.1007/s00401-024-02696-z.

Biochemical approaches to assess the impact of post-translational modifications on pathogenic tau conformations using recombinant protein

Alhadidy MM, Kanaan NM.

Biochem Soc Trans. 2024 Feb 28;52(1):301-318. doi: 10.1042/BST20230596.

Targeting Abnormal Tau Phosphorylation for Alzheimer's Therapeutics

Singh A, Ansari VA, Mahmood T, Hasan SM, Wasim R, Maheshwari S, Akhtar J, Sheikh S, Vishwakarma VK.

Horm Metab Res. 2024 Jul;56(7):482-488. doi: 10.1055/a-2238-1384. Epub 2024 Feb 13.

Epilepsy and epileptiform activity in late-onset Alzheimer disease: clinical and pathophysiological advances, gaps and conundrums

Kamondi A, Grigg-Damberger M, Löscher W, Tanila H, Horvath AA.

Nat Rev Neurol. 2024 Mar;20(3):162-182. doi: 10.1038/s41582-024-00932-4. Epub 2024 Feb 14.

Implications of organophosphate pesticides on brain cells and their contribution toward progression of Alzheimer's disease

Yadav B, Kaur S, Yadav A, Verma H, Kar S, Sahu BK, Pati KR, Sarkar B, Dhiman M, Mantha AK.

J Biochem Mol Toxicol. 2024 Mar;38(3):e23660. doi: 10.1002/jbt.23660.

Role of ketogenic diet in neurodegenerative diseases focusing on Alzheimer diseases: The guardian angle

Al-Kuraishy HM, Jabir MS, Albuhadily AK, Al-Gareeb AI, Jawad SF, Swelum AA, Hadi NR.

Ageing Res Rev. 2024 Mar;95:102233. doi: 10.1016/j.arr.2024.102233. Epub 2024 Feb 14.

Repetitive transcranial magnetic stimulation as a treatment for Alzheimer's disease: A randomized placebo-controlled double-blind clinical trial

Moussavi Z, Uehara M, Rutherford G, Lithgow B, Millikin C, Wang X, Saha C, Mansouri B, Omelan C, Fellows L, Fitzgerald PB, Koski L.

Neurotherapeutics. 2024 Apr;21(3):e00331. doi: 10.1016/j.neurot.2024.e00331. Epub 2024 Feb 14.

Alzheimer's therapeutic development: shifting neurodegeneration to neuroregeneration

Sun MK, Alkon DL.

Trends Pharmacol Sci. 2024 Mar;45(3):197-209. doi: 10.1016/j.tips.2024.01.012. Epub 2024 Feb 14.

Berberine: A Multi-Target Natural PCSK9 Inhibitor with the Potential to Treat Diabetes, Alzheimer's, Cancer and Cardiovascular Disease

Coppinger C, Pomales B, Movahed MR, Marefat M, Hashemzadeh M.

Curr Rev Clin Exp Pharmacol. 2024;19(4):312-326. doi: 10.2174/0127724328250471231222094648.

Obstructive Sleep Apnea and Alzheimer's Disease Pathology: Is Sleep Architecture the Missing Key?

Gills JL, Bubu OM.

J Alzheimers Dis. 2024;98(1):69-73. doi: 10.3233/JAD-231385.

Evolving therapeutic interventions for the management and treatment of Alzheimer's disease

Ahmad F, Karan A, Sharma R, Sharma NS, Sundar V, Jayaraj R, Mukherjee S, DeCoster MA.

Ageing Res Rev. 2024 Mar;95:102229. doi: 10.1016/j.arr.2024.102229. Epub 2024 Feb 15.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias